RBC Disorders Flashcards

1
Q

Basic principles of anemia

A

Reduction in circulating RBC mass
- Hgb < 13.5 g/dL in males and < 12.5 in females
Presents with signs and symptoms of hypoxia
- weakness, fatigue, dyspnea
- pale conjunctiva and skin
- headache and light headedness
- angina, especially with preexisting coronary artery disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Basic principles of microcytic anemias

A

Anemia with MCV < 80
Due to decreased production of hemoglobin
- RBC progenitor cells in the bone marrow are large and normally divide multiple times to produce smaller mature cells
- microcytosis is due to an extra division which occurs to maintain hemoglobin concentration
Hgb is made of heme and globin; heme is composed or iron and protoporphyrin
- decrease in any of these components leads to microcytic anemia
Microcytic anemias =
- iron deficiency anemia
- anemia of chronic disease
- sideroblastic anemia
- thalassemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Iron deficiency anemia

A

Due to decreased levels of iron = low heme = low hgb = microcytic anemia
Most common type of anemia - most common nutritional deficiency in the world
Iron is consumed in heme (meat derived) and non-heme (veggie derived) forms
- absorption occurs in the duodenum
- enterocytes have have heme and non-heme (DMT1) transporters - heme form is more readily absorbed
- enterocytes transport iron across the cell membrane into blood via ferroportin
- transferrin transports iron in the blood and delivers it to the liver and bone marrow macrophages for storage
- stored intracellular iron is bound to ferritin, which prevents iron from forming free radicals via the Fenton reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lab measurements of iron status

A
  • Serum iron - measure of iron in the blood
  • Total iron binding capacity (TIBC) - measure of transferrin molecules in the blood
  • % saturation - percentage of transferrin molecules that are bound by iron; normal = 33%
  • serum ferritin - reflects iron stores in macrophages and the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of iron deficiency

A

Usually caused by dietary lack or blood loss
- Infants - breast feeding (human milk is low in iron)
- children - poor diet
- adults - peptic ulcer disease in males and menorrhagia or pregnancy in females
- elderly - colon polyps/carcinoma in the western world; hookwork in the developing world
Other causes
- malnutrition
- malabsorption
- gastrectomy - acid aids iron absorption by maintaining the Fe2+ state, which is more readily absorbed than Fe3+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stages of iron deficiency

A
  1. Storage iron is depleted = decreased ferritin + increased TIBC
  2. Serum iron is depleted = decreased serum iron + decreased % saturation
  3. Normocytic anemia - bone marrow makes fewer, but normal sized RBCs
  4. Microcytic, hypochromic anemia - bone marrow makes smaller and fewer RBCs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Clinical features of iron deficiency

A
  • anemia
  • koilonychia
  • pica
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Laboratory findings in iron deficiency anemia

A
  • microcytic, hypochromic RBCs with increased RDW
  • decreased ferritin + increased TIBC
  • decreased serum iron + decreased % saturation
  • increased free erythrocyte protoporphyrin (FEP)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment of iron deficiency anemia

A

Supplemental iron - ferrous sulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Plummer Vinson syndrome

A

Iron deficiency anemia with esophageal web and atrophic glossitis - presents as anemia, dysphagia and beefy red tongue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Anemia of chronic disease

A

Anemia associated with chronic inflammation or cancer; most common type of anemia in hospitalized patients
Chronic disease results in production of acute phase reactants from the liver, including hepcidin
- hepcidin - sequesters iron in storage sites by limiting iron transfer from macrophages to erythroid precursors and suppressing EPO production –> aim is to prevent bacteria from accessing iron
- decreased available iron = decreased heme = decreased hgb = microcytic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Laboratory findings in anemia or chronic disease and treatment

A
  • increased ferritin + decreased TIBC
  • decreased serum iron + decreased % saturation
  • increased free erythrocyte protoporphyrin (FEP)
  • Tx: address underlying cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Sideroblastic anemia

A

Anemia due to defective protoporphyrin synthesis
Protoporphoryn is synthesized via a series of reactions
- aminolevulinic acid synthetase (ALAS) - converts succinyl CoA to aminolevulinic acid (ALA) using bit B6 as a cofactor = rate limiting step
- aminolevulinic acid dehydrogenase (ALAD) converts ALA to porphobilinogen
- additional reactions convert porphobilinogen to protoporphyrin
- ferrochelatase - attaches protoporphyrin to iron to make heme = final reaction, occurs in mitochondria
- iron is transferred to erythroid precursors and enters the mitochondria to form heme - if protoporphyrin is deficient, iron remains trapped in mitochondria
- iron laden mitochondria form a ring around the nucleus of erythroid precursors = ringed sideroblasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of sideroblastic anemia

A

Can be congenital or acquired
Congenital defect - most commonly involves ALAS = rate limiting step
Acquired defects
- alcoholism - mitochondrial poison
- lead poisoning - inhibits ALAD and ferrochelatase
- vit B6 deficiency - required cofactor for ALAS; most commonly seen as a side effect of isoniazid treatment for TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Laboratory findings in sideroblastic anemia

A
  • increased ferritin + decreased TIBC
  • increased serum iron + increased % saturation
  • iron overloaded state
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Basic principles of macrocytic anemia

A

Anemia with MCV > 100 - most commonly due to folate or vit B12 deficiency = megaloblastic anemia
Folate and vit B12 are necessary for synthesis of DNA precursors
- folate circulates in the serum as methyl tetrahydrofolate - removal of the methyl group allows for participation in the synthesis of DNA precursors
- methyl group is transferred to vit B12 (cobalamin)
- vit B12 then transfers methyl group to homocysteine, producing methionine
Lack of folate or vit B12 impairs synthesis of DNA precursors
- impaired division and enlargement of RBC precursors leads to megaloblastic anemia
- impaired division of granulocytic precursors leads to hypersegmented neutrophils
- megaloblastic change is also seen in rapidly dividing epithelial cells (eg intestinal)
Other causes of marcocytic anemia without megaloblastic change:
- alcoholism
- liver disease
- drugs (5-FU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Folate deficiency

A

Dietary folate is obtained from green veggies and some fruits
Absorbed in the jejunum
Folate deficiency develops within months - body stores are minimal
Causes:
- poor diet - alcoholics and the elderly
- increased demand - pregnancy, cancer, hemolytic anemia
- folate antagonists - methotrexate = inhibits dihydrofolate reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clinical and laboratory findings of folate deficiency

A
  • macrocytic RBCs and hypersegmented neutrophils (> 5 lobes)
  • glossitis - decreased turnover of epithelial cells
  • decreased serum folate
  • increased serum homocysteine = increased risk for thrombosis
  • normal methylmalonic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Vit B12 deficiency

A

Dietary vit B12 is complexed to animal derived proteins
- salivary gland enzymes liberate B12, which is then bound by R binder and carried through the stomach
- pancreatic proteases in the duodenum detach vit B12 from R binder
- B12 binds intrinsic factor (produced by gastric parietal cells) in small bowel - IF-B12 complex is absorbed in the ileum
B12 deficiency is less common than folate deficiency and takes years to develop due to large hepatic stores of B12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Causes of B12 deficiency

A

Pernicious anemia = most common cause - autoimmune destruction of parietal cells leads to IF deficiency
Other causes of B12 deficiency
- pancreatic insufficiency
- damage to terminal ileum - crohn’s or diphyllobothrium latum (fish tapeworm)
- dietary deficiency is rare - only vegans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Clinical and laboratory findings of B12 deficiency

A
  • macrocytic RBCs with hypersegmented neutrophils
  • glossitis
  • subacute combined degeneration of the spinal cord due to increased levels of methylmalonic acid - impairs spinal cord myelinization –> damage results in poor proprioception and vibratory sensation (posterior column) and spastic paresis (lateral corticospinal tract)
  • decreased serum B12
  • increased serum homocysteine = increased risk for thrombosis
  • increased methylmalonic acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Thalassemia

A

Anemia due to decreased synthesis of the globin chains of hemoglobin
- inherited mutation - carriers are protected against plasmodium falciparum malaria
- divided into alpha and beta thalassemia based on decreased production of alpha or beta globin chains
Normal types of hemoglobin:
- HbF = alpha2 gamma2
- HbA = alpha2 beta2
- HbA2 = alpha2 delta2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Alpha thalassemia

A

Usually due to gene deletion - normally, 4 alpha genes are present on chromosome 16

  • one gene deleted = asymptomatic
  • two genes deleted = mild anemia with increased RBC count
  • -> cis deletion (when both deletions occur on the same chromosome; seen in asians) associated with an increased risk of severe thalassemia in offspring
  • -> trans deletion (when one deletion occurs on each chromosome, seen in Africans)
  • three genes deleted = severe anemia - beta chains form tetramers (HbH) that damage RBCs –> HbH is seen on electrophoresis
  • four genes deleted = lethal in utero - hydrops fetalis - gamma chains form tetramers (Hb Barts) that damage RBCs –> Hb Barts is seen on electrophoresis
24
Q

Beta thalassemia

A

Usually due to gene mutations - point mutations in promoter or splicing site - seen in individuals of African and mediterranean descent

  • 2 beta genes are present on chromosome 11 - mutations result in absent or diminished production of the beta globin chain
  • divided into beta thalassemia minor and major
25
Q

Beta thalassemia minor

A

Mildest form of disease and is usually asymptomatic with an increased RBC count

  • one normal copy of beta gene and one with diminished activity
  • microcytic, hypochromic RBCs and target cells are seen on blood smear
  • hgb electrophoresis shows slightly decreased HbA with increased HbA2 and HbF
26
Q

Beta thalassemia major

A

Most severe form of disease and presents with severe anemia a few months after birth - high HbF at birth is temporarily protective

  • two copies of defective gene with absent beta globin production
  • alpha tetramers aggregate and damage RBCs, resulting in ineffective erythropoiesis and extravascular hemolysis (removal or circulating RBCs by the spleen)
  • massive erythroid hyperplasia ensues resuting in
    1. expansion of hematopoeisis into the skull (reactive bone formation leads to crewcut appearance of x ray) and facial bones (chipmunk facies)
    2. extramedullary hematopoiesis with hepatosplenomegaly
    3. risk of aplastic crisis parvovirus B19 infection of erythroid precursos
  • chronic transfusions are often necessary; leads to risk for secondary hemochromatosis
  • smear shows microcytic, hypochromic RBCs with target cells and nucleated RBCs
  • electrophoresis shows HbA2 and HbF with little or no HbA
27
Q

Basic principles of normocytic anemia

A
  • anemia with normal sized RBCs (MCV + 80-100)
  • due to increased peripheral destruction or underproduction –> reticulocyte count helps to distinguish between these two etiologies
28
Q

Reticulocytes

A

Young RBCs released from the bone marrow - identified on blood smear as larger cells with bluish cytoplasm due to residual RNA

  • normal reticulocyte count is 1-2%
  • RBC lifespan is 120 days - each day roughly 1-2% of RBCs are removed from circulation and replaced by reticulocytes
  • a properly functioning marrow responds to anemia by increased the RB to >3%

RC is falsely elevated in anemia –> RC is measured as a percentage of total RBCs, so a decrease in total RBCs falsely elevated percentage of reticulocytes

  • RC is corrected by multiplying reticulocyte count by Hct/45
  • corrected count >3% = good marrow response - suggests peripheral destruction
  • corrected count <3% = poor marrow response - suggests underproduction
29
Q

Peripheral RBC destruction = hemolysis

A

Divided into extravascular and intravascular hemolysis - both result in anemia with a good marrow response

Predominantly extravascular hemolysis:

  1. hereditary spherocytosis
  2. sickle cell anemia
  3. hemoglobin C

Predominantly intravascular hemolysis:

  1. paroxysmal nocturnal hemoglobinuria
  2. G6PD deficiency
  3. immune hemolytic anemia
  4. microangiopathic hemolytic anemia
  5. malaria
30
Q

Extravascular hemolysis

A

Involves RBC destruction by the reticuloendothelial system = macrophages of the spleen, liver and lymph nodes

  • macrophages consume RBCs and break down hemoglobin
  • globin –> broken down into amino acids
  • heme –> broken down into iron + protoporphorin
  • iron –> recycled
  • protoporphorin –> broken down into unconjugated bilirubin - bound to serum albumin and delivered to the liver for conjugation and excretion into bile

Clinical and lab findings:

  • anemia with splenomegaly
  • jaundice due to unconjugated bilirubin
  • increased risk for bilirubin gallstones
  • marrow hyperplasia with corrected reticulocyte count >3%
31
Q

Intravascular hemolysis

A

Involves destruction of RBCs within vessels

Clinical and lab findings:

  • hemoglobinemia
  • hemoglobinuria
  • hemosiderinuria –> renal tubular cells pick up some of the hemoglobin that is filtered into the urine and break it down into iron, which accumulates as hemosiderin –> tubular cells are eventually shed resulting in hemosiderinuria
  • decreased serum haptoglobin
32
Q

Hereditary spherocytosis

A

Inherited defect of RBC cytoskeleteon-membrane tethering proteins

  • most commonly involves ankyrin, spectrin, or band 3
  • membrane blebs are formed and lost over time
  • loss of membrane renders cells round (spherocytes) instead of disc shaped
  • spherocytes are less able to maneuver through splenic sinusouds and are consumed by splenic macrophages –> results in anemia
33
Q

Clinical and lab findings in hereditary spherocytosis

A
  • spherocytes with loss of central pallor
  • increased RDW and MCHC
  • splenomegaly
  • jaundice with unconjugated bilirubin
  • increased risk for bilirubing gallstones due to extravascular hemolysis
  • increased risk for aplastic crisis with parvovirus B19 infection of erythroid precursors
34
Q

Diagnosis and treatment of hereditary spherocytosis

A

Diagnosis: Osmotic fragility test –> reveals increased spherocyte fragility in hypotonic solution because RBCs don’t have extra membrane in which they can expand

Treatment: Splenectomy –> anemia resolves but spherocytes persist
- Howell-Jolly bodies (fragments of nuclear material in RBCs normally removed by spleen) emerge on blood smear

35
Q

Sickle cell anemia

A

Autosomal recessive mutation in beta chain of hemoglobin = a single amino acid change replaces normal glutamic acid (hydrophillic) with valine (hydrophobic)

  • gene is carried by 10% of African individuals likely due to protective role against falciparum malaria
  • sickle cell disease arises when two abnormal beta genes are present; results in > 90% HbS in RBCs

HbS polymerizes when deozygenated - polymers aggregate into needle like structures, resulting in sickle cells

  • increased risk of sickling occurs with hypoxemia, dehydration and acidosis
  • HbF protects against sickling –> high HbF at birth is protective for the first few months of life
  • Treatment with hydroxyurea increases levels of HbF
36
Q

Pathogenesis of sickle cell disease

A

Cells continuously sickle and de-sickle while passing through the microcirculation - results in complications related to RBC membrane damage

  • extravascular hemolysis –> reticuloendothelial system removes RBCs with damaged membranes, leading to anemia, jaundice with unconjugated hyperbilirubinemia and increased risk for bilirubing gallstones
  • intravascular hemolysis –> RBCs with damaged membranes dehydrate, leading to hemolysis with decreased haptoglobin and target cells on blood smear
  • massive erythroid hyperplasia ensues =
  • -> expansion of hematopoiesis into skull and facial bones
  • -> extramedullary hematopoeisis with hepatomegaly
  • -> risk of aplastic crisis with parvovirus B19 infection of erythroid precursors
37
Q

Consequences of irreversible sickling in sickle cell disease

A

Leads to complications of vaso-occlusion

  1. dactylitis = swollen hands and feet due to vaso-occlusive infarcts in bones - common presenting sign in infants
  2. autosplenectomy = shrunken, fibrotic spleen
    - -> increased risk of infection with encapsulated organisms such as strep pneumo and h. flu = most common cause of death in children
    - -> increased risk of salmonella paratyphi osteomyelitis
    - -> Howell-jolly bodies on blood smear
  3. acute chest syndrome = vaso-occlusion in pulmonary microcirculation
    - -> presents with chest pain, shortness of breath, and lung infiltrates
    - -> often precipitated by pneumonia
    - -> most common cause of death in adult patients
  4. pain crisis
  5. renal papillary necrosis –> results in gross hematuria and proteinuria
38
Q

Sickle cell trait

A

The presence of one mutated and one normal beta chain –> results in results in microinfarctions leading to microscopic hematuria, and eventually decreased ability to concentrate urine

39
Q

Lab findings in sickle cell disease

A
  • sickle cells and target cells are seen on blood smear in sickle cell disease, but not in sickle cell trait
  • metabisulfite screen causes cells with any amount of HbS to sickle –> positive in both disease and trait
  • Hb electrophoresis confirms the presence and amount of HbS
  • disease = 90% HbS, 8% HbF, 2% HbA2 (no HbA)
  • trait = 55% HbA, 43% HbS, 2% HbA2
40
Q

Hemoglobin C

A

Autosomal recessive mutation in beta chain of hemoglobin

  • normal glutamic acid is replaced by lysine
  • less common than sickle cell disease
  • presents with mild anemia due to extravascular hemolysis
  • characteristic HbC crystals are seen in RBCs on blood smear
41
Q

Paroxysmal nocturnal hemoglobinuria

A

Acquired defect in myeloid stem cells resulting in absent GPI –> renders cells susceptible to destruction by complement

  • blood cells coexist with complement
  • decay accelerating factor (DAF) on the surface of blood cells protects against complement mediated damage by inhibiting C3 convertase
  • DAF is secured to the cell membrane by GPI
  • absence of GPI = absence of DAF –> renders cells susceptible to complement mediated damage

Intravascular hemolysis occurs episodically, often at night during sleep

  • mild respiratory acidosis develops with shallow breathing during sleep and activates complement
  • RBCs, WBCs, and platelets are lysed
  • intravascular hemolysis leads to hemoglobineamia and hemoglobinuria (especially in the morning)
  • hemosiderinuria is seen days after hemolysis

Main cause of death is thrombosis of the hepatic, portal or cerebral veins –> destroyed platelets release cytoplasmic contents into circulation, inducing thrombosis

Complications

  • iron deficiency anemia due to chronic loss of hemoglobin in the urine
  • AML develops in 10% of patients
42
Q

Testing for PNH

A
  • sucrose test is used to screen for disease

- confirmatory test is the acidifed serum test or flow cytometry to detect lack of CD55 (DAF) on RBCs

43
Q

G6PD deficiency

A

X linked recessive disorder resulting in reduced half life of G6PD –> renders cells susceptible to cell stress

  • RBCs are normally exposed to oxidative stress, particularly H2O2
  • glutathione (antioxidant) –> neutralizes H2O2 but becomes oxidized in the process
  • NADPH = a byproduct of G6PD –> needed to regenerate reduced glutathione
  • decreased G6PD = decreased NADPH = reduced glutathione = oxidative injury by H2O2 = intravascular hemolysis
44
Q

Variants of G6PD deficiency

A
  1. African variant = mildly reduced half life of G6PD –> mild intravascular hemolysis with oxidative stress
  2. Mediteranean variant = markedly reduced half life of G6PD –> marked intravascular hemolysis with oxidative stress

High carrier frequency in both populations is likely due to protective role against falciparum malaria

45
Q

Consequences of oxidative stress in G6PD deficiency

A

Oxidative stress precipitates Hb as Heinz bodies

  • causes of oxidative stress include infection, drugs (primaquine, sulfa drugs, dapsone) and fava beans
  • heinz bodies are removed from RBCs by splenic macrophages –> results in bite cells
  • leads to predominantly intravascular hemolysis

Presents with hemoglobinuria and back pain hours after exposure to oxidative stress

46
Q

Screening for G6PD deficiency

A

Heinz preparation - precipitated hemoglobin can only be seen with a special Heinz stain
- enzyme studies confirm deficiency –> performed weeks after hemolytic episode resolves

47
Q

Immune hemolytic anemia

A

Antibody mediated destruction of RBCs (IgG or IgM)

  • IgG mediated disease usually involves extravascular hemolysis
  • IgM mediated disease usually involves intravascular hemolysis
48
Q

IgG mediated immune hemolytic anemia

A

IgG binds RBCs in the relatively warm temperature of the central body = warm agglutinin –> membrane of antibody coated RBC is consumed by splenic macrophages –> results in spherocytes

  • associated with SLE (most common cause), CLL and certain drugs (penicillin and cephalosporin)
  • drugs may attach to RBC membrane with subsequent binding of antibody to drug membrane complex
  • drug may induce production of autoantibodies that bind self antigens on RBCs

Treatment:

  • cessation of drugs
  • steroids
  • IVIG
  • splenectomy
49
Q

IgM mediated immune hemolytic anemia

A

IgM binds RBCs and fixes complement in the relatively cold temperature of the extremities = cold agglutinin
- associated with mycoplasma pneumoniae and infectious mononucleosis

50
Q

Diagnosis of immune hemolytic anemia

A

Coombs test

  1. Direct Coombs test = confirms the presence of antibody coated RBCs
    - -> Anti-IgG is added to patient RBCs - agglutination occurs if RBCs are already coated with antibody
    - -> most important test for IHA
  2. Indirect Coombs test = confirms presence of antibodies in patient serum
    - -> Anti-IgG and test RBCs are mixed with the patient serum
    - -> agglutination occurs if serum antibodies are present
51
Q

Microangiopathic hemolytic anemia

A

Intravascular hemolysis that results from vascular pathology –> RBCs are destroyed as they pass through the circulation

  • iron deficiency anemia occurs with chronic hemolysis
  • occurs with microthrombi (TTP-HUS, DIC, HELLP), prosthetic heart valves and aortic stenosis
  • produce schistocytes on blood smear
52
Q

Malaria

A

Infection of RBCs and liver with plasmodium –> transmitted by female anopheles mosquito

  • RBCs rupture as a part of the plasmodium life cycle, resulting in intravascular hemolysis and cyclical fever
  • p. falciparum = daily fever
  • p vivax and ovale = every other day fever
  • spleen also consumes some infected RBCs –> results in mild extravascular hemolysis with splenomegaly
53
Q

Anemia due to underproduction

A

Decreased production of RBCs by bone marrow –> characterized by low corrected reticulocyte count

Etiologies:

  • causes of microcytic and macrocytic anemia
  • renal failure –> decreased production of EPO by peritubular interstitial cells
  • damage to bone marrow precursor cells –> may result in anemia or pancytopenia
54
Q

Parvovirus B19

A
  • infects progenitor red cells and temporarily halts erythropoiesis –> leads to significant anemia in the setting of preexisting marrow stress (eg sickle cell)
  • treatment is supportive
55
Q

Aplastic anemia

A

Damage to hematopoietic stem cells –> results in pancytopenia with low reticulocyte count

Etiologies

  • drugs/chemicals
  • viral infections
  • autoimmune damage

Biopsy reveals an empty, fatty marrow

Treatment:

  • cessation of any causative drugs
  • supportive care with transfusions and marrow stimulating factors = EPO, GM-CSF, G-CSF
  • immunosuppression may be helpful as some idiopathic cases are due to abnormal T cell activation with release of cytokines
  • bone marrow transplant is a last resort
56
Q

Myelophthisic process

A

Pathologic process that replaces bone marrow –> eg. metastatic cancer
- hematopoiesis is impaired –> results in pancytopenia